Software medical device developer Argus Cognitive has announced its ReVISION platform has received (510k) FDA clearance. ReVISION allows medical professionals to better diagnose and stratify right ventricular dysfunction in patients with cardiopulmonary diseases, according to the August 15 company statement.
Doha: Qatar Biomedical Research Institute (QBRI), part of Qatar Foundation s Hamad Bin Khalifa University (HBKU), signed an agreement with Argus Cogni.
The Qatar Biomedical Research Institute (QBRI) which is a part of Qatar Foundation (QF)’s Hamad Bin Khalifa University has made pathways with a special tool that.
Doha: Qatar Biomedical Research Institute (QBRI), part of Qatar Foundation s Hamad Bin Khalifa University (HBKU), signed an agreement with Argus Cogni.